Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2012
10/10/2012CN102725403A Methods and compositions for treating oxalate-related conditions
10/10/2012CN102725312A Protein agent for diabetes treatment and beta cell imaging
10/10/2012CN102725311A Methods of treating inflammation
10/10/2012CN102725308A Fibronectin: growth factor chimeras
10/10/2012CN102724995A Fibrinogen preparations enriched in fibrinogen with an extended alpha chain
10/10/2012CN102724994A Method for treatment of inflammatory disease and disorder
10/10/2012CN102724993A Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
10/10/2012CN102724992A Recombinant production of peptides
10/10/2012CN102724985A Use of lipid conjugates in the treatment of diseases associated with vasculature
10/10/2012CN102724980A Therapeutic use of protein-polymer conjugates
10/10/2012CN102724968A Dry powder fibrin sealant
10/10/2012CN102724966A Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof
10/10/2012CN102724886A Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof
10/10/2012CN102719478A Chimpanzee adenovirus vaccine carriers
10/10/2012CN102719470A Cloning, expressing and protein-purifying method for OPN gene
10/10/2012CN102719460A A gloydiusussuriensi thrombin-like gene and application thereof
10/10/2012CN102719439A Mutant human epidermal growth factor gene, protein, preparation methods for mutant human epidermal growth factor gene and protein, and application of mutant human epidermal growth factor gene and protein
10/10/2012CN102719411A Microbial transglutaminase and application thereof
10/10/2012CN102719397A Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus)
10/10/2012CN102718870A Insulin bio-sensitizer and application thereof
10/10/2012CN102718868A Fixed point mono-substituted pegylation of Exendin analogue and preparation method thereof
10/10/2012CN102718858A Glucagon-like peptide-1 (GLP-1) analogue monomer and dimer, preparation method therefor and application thereof
10/10/2012CN102718857A Denatured protein powder and brain protein hydrolyzate prepared from same
10/10/2012CN102718856A Recombinant chromatin modified albumin 1A, as well as coding gene and application thereof
10/10/2012CN102718847A Small molecular superantigen modified protein, its encoding gene, preparation process and application thereof
10/10/2012CN102718846A Activity-increased SEC 2 mutant protein, coding gene, preparation and application
10/10/2012CN102718844A Antimicrobial peptide AMitP with acid activation property and synthesis and application thereof in preparation of anti-tumor medicaments
10/10/2012CN102718838A Short peptide and immunosuppressant containing the same and application
10/10/2012CN102718837A Short peptide, immunosuppressant containing short peptide, and applications
10/10/2012CN102718836A Short peptide, immune inhibitor containing the same and application thereof
10/10/2012CN102718835A Short peptide and immunosuppressant containing the same and application
10/10/2012CN102718834A Specific inhibitor of human immune system toxic protein granzyme H, its preparation method and application
10/10/2012CN102716481A Immunoadjuvant of oral vaccine for tilapia and use thereof
10/10/2012CN102716471A Anti-hyperlipidemia health-care product
10/10/2012CN102716470A Medicine composite for treating peripheral nerve injury
10/10/2012CN102716469A Dry powder inhalant of interferon alpha
10/10/2012CN102716468A Application of antagonist G31P in preparing medicine for preventing cisplatin-caused acute renal failure
10/10/2012CN102716467A Application of hepatocyte growth factor in preparation of medicines for treating multiple sclerosis
10/10/2012CN102716466A Application of major histocompatibility complex II (MHC II) molecules on preparation of drugs for preventing and curing animal immunodepression
10/10/2012CN102716465A Pharmaceutical composite for treating tumor and preparation method of pharmaceutical composite
10/10/2012CN102716464A Application of oligopeptide to preparation of medicine for treating angiogenesis ophthalmic diseases
10/10/2012CN102716463A Glycyrrhizic acid organic salt phospholipid ligand and preparation thereof
10/10/2012CN102716462A Pharmaceutical composition taking ambroxol and pidotimod as active ingredients
10/10/2012CN102716164A Echinacea extract and preparation method of echinacea extract
10/10/2012CN102716105A Dry powder inhalant of interferon Alpha
10/10/2012CN102416165B Aerosol inhalation agent containing interferon alpha and dexamethasone sodium phosphate
10/10/2012CN102206667B Recombinant plasmid pET32a-hIL-23R-CHR and construction and expression thereof
10/10/2012CN101933653B Officinal health-care solid electronic aerosolization liquid and preparation method thereof
10/10/2012CN101914546B Amphioxus saccharide pattern-recognition molecule Bjfcn1 gene and application thereof
10/10/2012CN101906156B Structures and application of bifunctional protein and derivatives of bifunctional protein
10/10/2012CN101899469B Shuttle plasmid and method for efficiently expressing cecropin and lysozyme genes
10/10/2012CN101899105B Recombinant erythropoietin and preparation method thereof
10/10/2012CN101817878B Monomer quick-acting insulin as well as preparing method and application thereof
10/10/2012CN101804192B CTLA4lg and derivatives thereof used for resisting tumors
10/10/2012CN101745095B Composition of reduced glutathione and sodium carbonate or sodium bicarbonate
10/10/2012CN101649311B Preparation method of human lysozyme-antibacterial peptide Catesbeianin-1 fusion protein and application of same on preventing and curing cow mastitis
10/10/2012CN101596311B Stable kallikrein-1 injection
10/10/2012CN101491681B Medicine containing PEG human growth hormone conjugate and use thereof
10/10/2012CN101444624B Medicine for cancer therapy
10/10/2012CN101389650B Compositions comprising an acylated insulin and zinc and method of making the said compositions
10/10/2012CN101370825B Novel FSH glycosylation variant D3N
10/10/2012CN101351550B Chimaeric fusion protein with superior chaperone and folding activities
10/10/2012CN101287988B Methods and compositions for diagnosis and treatment of influenza
10/10/2012CN101287484B Binding agents which inhibit myostatin
10/10/2012CN101242852B Methods of protecting against apoptosis using lipopeptides
10/10/2012CN101203234B Milk fat globule epidermal growth factor VIII and sepsis
10/10/2012CN101151276B Method of producing protein by using hamster IGF-1
10/10/2012CN101098623B Application of antioxidant for gene adjustment
10/10/2012CN101083907B Compositions and methods for topical diagnostic and therapeutic transport
10/10/2012CN101082043B Polyethylene glycol modified L-asparaginyl amine enzyme
10/09/2012US8283462 Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof
10/09/2012US8283461 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
10/09/2012US8283459 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
10/09/2012US8283448 Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
10/09/2012US8283445 Extracellular-signal-regulated-kinase (ERK) heteropolyligand polypeptide
10/09/2012US8283444 Non-viral delivery of compounds to mitochondria
10/09/2012US8283442 Antiviral compounds
10/09/2012US8283440 Snapin and methods for regulation of microtubule assembly and dendrite growth and branching
10/09/2012US8283414 Compositions comprising modified collagen and uses therefor
10/09/2012US8283334 Inhibitors of TGF-R signaling for treatment of CNS disorders
10/09/2012US8283330 Modulators of pharmacological agents
10/09/2012US8283329 Genetic inhibition of double-stranded RNA
10/09/2012US8283325 Tuning the morphology or texture of lithium-intercalated materials to produce porous, high surface area composites; transition metal oxides coordinated with a peptide exhibiting an affinity for a reduced form of the metal; thin films; rechargeable batteries
10/09/2012US8283324 Immunomodulatory and anti-tumour peptides
10/09/2012US8283322 Formulations for nonsurgical exogenous crosslink therapy
10/09/2012US8283321 Kallikrein-binding “Kunitz domain” proteins and analogues thereof
10/09/2012US8283320 Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostasis
10/09/2012US8283319 Therapeutic application of Kazal-type serine protease inhibitors
10/09/2012US8283318 Aquaretic and natriuretic polypeptides lacking vasodilatory activity
10/09/2012US8283317 Nanoparticles for protein drug delivery
10/09/2012US8283316 Methods for treating radiation burns
10/09/2012US8283314 Skin care compositions
10/09/2012US8283313 Methods of increasing platelet and hematopoietic stem cell production
10/09/2012US8283312 Compositions and methods for modulating body weight and treating obesity-related disorders
10/09/2012US8283311 Peptide-containing food intake regulator
10/09/2012US8283310 Hepatitis C virus inhibitors
10/09/2012US8283309 Bridged carbocyclic oxime hepatitis C virus serine protease inhibitors
10/09/2012US8283308 Copolymer-stabilized emulsions
10/09/2012US8283307 Treatment of fibrotic disease
10/09/2012US8283167 Preparation of annexin derivatives
1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 3163